HSP90 identified by a proteomic approach as druggable target to reverse platinum resistance in ovarian cancer.
Lombardi R, Sonego M, Pucci B, Addi L, Iannelli F, Capone F, Alfano L, Roca MS, Milone MR, Moccia T, Costa A, Di Gennaro E, Bruzzese F, Baldassarre G, Budillon A.
Lombardi R, et al. Among authors: addi l.
Mol Oncol. 2021 Apr;15(4):1005-1023. doi: 10.1002/1878-0261.12883. Epub 2021 Jan 19.
Mol Oncol. 2021.
PMID: 33331136
Free PMC article.